SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing a massive surge driven by intense short-squeeze dynamics and investor anticipation of pivotal phase 3 clinical trial results. The community is focused on the impending 80th event milestone, which will trigger trial unblinding and serves as a major catalyst fueling speculation about potential buyout interest from big pharma.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently facing intense selling pressure and bearish sentiment, with investors debating whether the stock is a value opportunity or caught in a structural downtrend amid ongoing concerns over management execution and adtech sector volatility. Community discussion is heavily focused on the company's lack of substantive news at the Cannes Lions event, skepticism toward the CEO's leadership, and the stock's persistent underperformance relative to broader market momentum.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending after the announcement of its divestiture of Del Taco, a move aimed at streamlining operations and reducing debt levels. Community sentiment is deeply polarized, with some investors betting on a potential short squeeze due to high short interest and a low float, while others express concerns over the company's significant debt load and the strategic loss taken on the Del Taco sale.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing a surge in volatility and trader interest as the community reacts to an expanding robotaxi partnership with Uber and Nuro, alongside ongoing discussions about significant workforce reductions and structural cost-saving initiatives. Investors are closely monitoring a massive spike in borrow rates and low share availability, fueling widespread speculation among community members regarding the potential for a short squeeze.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor attention driven by recent insider buying from the CEO and optimism surrounding its AI-powered credit infrastructure, despite ongoing volatility from macroeconomic concerns and index rebalancing. The community remains focused on the company's path to profitability and potential for a short squeeze, while debating whether current price levels represent a deep value opportunity or reflect underlying risks.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending due to the company's major strategic announcement to spin off its media assetsincluding NBCUniversal and Skyinto a separate public company, a move investors are weighing as a potential catalyst to unlock long-term shareholder value. The community is actively debating the implications of this separation, with many focused on whether this leaner structure will revitalize the stock or if persistent concerns about the media landscape and cable cord-cutting will continue to weigh on market sentiment.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is experiencing heightened volatility and active community speculation following its recent inclusion in the Russell 3000 index and ongoing discussions regarding its BPL-003 lead asset. While shareholders are closely monitoring potential partnership developments and clinical trial timelines, the stock remains a focal point for investors weighing its long-term pipeline value against broader biotech sector sentiment.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors react to a newly announced bitcoin monetization program, which allows the company to sell holdings to fund share repurchases and stabilize its capital structure. Community sentiment is deeply divided, with bulls viewing the shift as a necessary and accretive strategic evolution, while skeptics warn it signals long-term instability and a departure from the company's core bitcoin accumulation thesis.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is facing significant selling pressure as investors react to management's revised growth outlook for its Watchman product line, driving the stock to fresh yearly lows. While the community is debating whether this decline represents a major buying opportunity or a deeper value trap, many are pointing to the company's aggressive share repurchase program as a potential support level for a future recovery.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to the company's recent move to repurchase convertible debt, which many in the community interpret as a strategic signal of management's confidence ahead of potential catalysts. While the stock has faced downward pressure, the community is focused on the upcoming J-code activation, anticipated EMA regulatory developments, and potential milestone payments from the Novo Nordisk partnership as key drivers for long-term value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Kicking_Bear

Kicking Bear